2023-08-01 2024-07-31 false Capium Accounts Production 1.1 04847151 2023-08-01 2024-07-31 04847151 bus:FullAccounts 2023-08-01 2024-07-31 04847151 bus:FRS102 2023-08-01 2024-07-31 04847151 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 04847151 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 04847151 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 04847151 2023-08-01 2024-07-31 04847151 2024-07-31 04847151 bus:RegisteredOffice 2023-08-01 2024-07-31 04847151 core:WithinOneYear 2024-07-31 04847151 core:AfterOneYear 2024-07-31 04847151 1 2023-08-01 2024-07-31 04847151 bus:Director1 2023-08-01 2024-07-31 04847151 bus:Director1 2024-07-31 04847151 bus:Director1 2022-08-01 2023-07-31 04847151 2022-08-01 04847151 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 04847151 2022-08-01 2023-07-31 04847151 2023-07-31 04847151 core:WithinOneYear 2023-07-31 04847151 core:AfterOneYear 2023-07-31 04847151 bus:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 04847151 core:PlantMachinery 2023-08-01 2024-07-31 04847151 core:PlantMachinery 2024-07-31 04847151 core:PlantMachinery 2023-07-31 04847151 core:ComputerEquipment 2023-08-01 2024-07-31 04847151 core:ComputerEquipment 2024-07-31 04847151 core:ComputerEquipment 2023-07-31 04847151 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 04847151 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 04847151 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 04847151 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 04847151 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 04847151 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 04847151 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 04847151 core:Non-currentFinancialInstruments 2024-07-31 04847151 core:Non-currentFinancialInstruments 2023-07-31 04847151 core:ShareCapital 2024-07-31 04847151 core:ShareCapital 2023-07-31 04847151 core:RetainedEarningsAccumulatedLosses 2024-07-31 04847151 core:RetainedEarningsAccumulatedLosses 2023-07-31 04847151 core:ShareCapitalOrdinaryShares 2023-08-01 04847151 core:ShareCapitalOrdinaryShares 2022-08-01 04847151 core:ShareCapitalOrdinaryShares 2023-08-01 2024-07-31 04847151 core:ShareCapitalOrdinaryShares 2022-08-01 2023-07-31 04847151 core:ShareCapitalOrdinaryShares 2024-07-31 04847151 core:ShareCapitalOrdinaryShares 2023-07-31 04847151 core:RetainedEarningsAccumulatedLosses 2023-08-01 04847151 core:RetainedEarningsAccumulatedLosses 2022-08-01 04847151 core:RetainedEarningsAccumulatedLosses 2023-08-01 2024-07-31 04847151 core:RetainedEarningsAccumulatedLosses 2022-08-01 2023-07-31 04847151 core:RetainedEarningsAccumulatedLosses 2024-07-31 04847151 core:RetainedEarningsAccumulatedLosses 2023-07-31 04847151 dpl:Item1 2023-08-01 04847151 dpl:Item1 2024-07-31 04847151 dpl:Item1 2022-08-01 04847151 dpl:Item1 2023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 04847151
England and Wales

 

 

 

MAC MEDICINE LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 August 2023

End date: 31 July 2024
Director Ali Musa
Registered Number 04847151
Registered Office 77 Auden Place
London
United Kingdom
NW1 8ND
Accountants Worth Knowing Accountants Ltd
7 Bell Yard
London
WC2A 2JR
1
Director's report and financial statements
The director presents his/her/their annual report and the financial statements for the year ended 31 July 2024
Principal activities
Principal activity of the company during the financial year was of Repair of computers and peripheral equipment.
Director
The director who served the company throughout the year was as follows:
Ali Musa
Statement of director's responsibilities
The director is responsible for preparing the directors’ report and the financial statements in accordance with applicable law and regulation.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to
  • select suitable accounting policies and then apply them consistently
  • make judgments and accounting estimates that are reasonable and prudent
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business


The director is responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

On behalf of the board.


----------------------------------
Ali Musa
Director

Date approved: 13 January 2025
2
Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 July 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Worth Knowing Accountants Ltd
31 July 2024



....................................................
Worth Knowing Accountants Ltd
7 Bell Yard
London
WC2A 2JR
13 January 2025
3
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 1,242    1,656 
1,242    1,656 
Current assets      
Debtors 4 2,285    1,225 
Cash at bank and in hand 5,894    12,536 
8,179    13,761 
Creditors: amount falling due within one year 5 (25,308)   (14,397)
Net current assets (17,129)   (636)
 
Total assets less current liabilities (15,887)   1,020 
Net assets (15,887)   1,020 
 

Capital and reserves
     
Called up share capital 1,000    1,000 
Profit and loss account (16,887)   20 
Shareholders' funds (15,887)   1,020 
 


For the year ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 13 January 2025 and were signed by:


-------------------------------
Ali Musa
Director
4
  Equity share capital   Retained Earnings   Total
£ £ £
At 01 August 2022 1,000  2  1,002 
Profit for the year 35,718  35,718 
Total comprehensive income for the year 35,718  35,718 
Dividends (35,700) (35,700)
Total investments by and distributions to owners (35,700) (35,700)
At 31 July 2023 1,000  20  1,020 
At 01 August 2023 1,000  20  1,020 
Profit for the year 31,093  31,093 
Total comprehensive income for the year 31,093  31,093 
Dividends (48,000) (48,000)
Total investments by and distributions to owners (48,000) (48,000)
At 31 July 2024 1,000  (16,887) (15,887)
5
General Information
Mac Medicine Ltd is a private company, limited by shares, registered in England and Wales, registration number 04847151, registration address 77 Auden Place, London, United Kingdom, NW1 8ND.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Website cost
Planning and operating costs for the company's website are charged to the income statement as incurred.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 25% Reducing Balance
Computer Equipment 25% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Computer Equipment   Total
  £   £   £
At 01 August 2023 7,462    7,252    14,714 
Additions    
Disposals    
At 31 July 2024 7,462    7,252    14,714 
Depreciation
At 01 August 2023 7,216    5,842    13,058 
Charge for year 62    352    414 
On disposals    
At 31 July 2024 7,278    6,194    13,472 
Net book values
Closing balance as at 31 July 2024 184    1,058    1,242 
Opening balance as at 01 August 2023 246    1,410    1,656 


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Trade Debtors 2,285    1,225 
2,285    1,225 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax 7,342    8,370 
Accrued Expenses 900    900 
Directors' Current Accounts 17,066    5,127 
25,308    14,397 

6